A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests - GLP-1 drugs may interfere with ...

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

But now, a scientific study has revealed the surprising way that weight loss and type 2 diabetes drugs could be helping you ...

Along with the boxed warning, FDA will require a statement on product labeling indicating that TXA injection is contraindicated as a neuraxial injection, and have the dose and administration section ...

Weight-loss injections such as Ozempic and Wegovy are transforming how people manage obesity, but doctors are now noticing ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...